The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
Autosomal Dominant Polycystic Kidney Disease from childhood to adulthood, including a patient’s perspective
YPNN (ESPN) – YNP (ERA) Joint e-seminar
Opening
Evgenia Preka, UK (ESPN-YPNN)
Orsolya Cseprekál, Hungary (YNP)
The paediatric nephrologist’s perspectives
Djalila Mekahli, University Hospital Leuven, Belgium
The adult nephrologist’s perspective
Esther Meijer, University Medical Center Groningen, Netherlands
The patient’s perspectives
Holly Elizabeth Finch, UK
Panellists discussion
Ewa Pawłowicz, Medical University of Lodz Poland (YNP)
Fabio Paglialonga, Ospedale Maggiore Policlinico, Milano, Italy (ESPN-YPNN)
Closing remarks
Evgenia Preka, UK (ESPN-YPNN)
Orsolya Cseprekál, Hungary (YNP)